Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting, 62310-62311 [2018-26188]

Download as PDF khammond on DSK30JT082PROD with NOTICES 62310 Federal Register / Vol. 83, No. 232 / Monday, December 3, 2018 / Notices hold its 175th Council meeting by teleconference and webinar to take actions on fishery management issues in the Western Pacific Region. The Council will also hold a meeting of the Protected Species Advisory Committee (PSAC) by teleconference and webinar. DATES: The meetings will be held on December 17, 2018. For specific times and agendas, see SUPPLEMENTARY INFORMATION. ADDRESSES: The meetings will be held by teleconference and webinar. The teleconference numbers are: U.S. tollfree: (888) 482–3560 or International Access: +1(647) 723–3959, and Access Code: 5228220; the webinar can be accessed at: https://wprfmc.webex.com/ join/info.wpcouncilnoaa.gov. The following venue also will be a host site for the PSAC meeting teleconference: Council Conference Room, 1164 Bishop Street, Suite 1400, Honolulu, HI. The following venues will also be host sites for the 175th Council Meeting teleconference: Council Conference Room, 1164 Bishop Street, Suite 1400, Honolulu, HI; Native American Samoa Advisory Council Office Conference Room, Pava’ia’i Village, Pago Pago, American Samoa; Guam Hilton Resort and SPA, 202 Hilton Road, Tumon Bay, Guam; Department of Land and Natural Resources Conference Room, Lower Base Drive, Saipan, MP. FOR FURTHER INFORMATION CONTACT: Contact Kitty M. Simonds, Executive Director, Western Pacific Fishery Management Council; phone: (808) 522– 8220. SUPPLEMENTARY INFORMATION: The PSAC meeting will be held between 9 a.m. and 11 a.m. on December 17, 2018 (Hawaii Standard Time (HST)). The 175th Council Meeting will be held on December 17, 2018, between 12 p.m. and 2 p.m. (HST); 11 a.m. and 1 p.m. (American Samoa Standard Time (ASST)); and December 18, 2018, between 8 a.m. and 10 a.m. (Marianas Standard Time (MST)). Agenda items noted as ‘‘Final Action Items’’ refer to actions that result in Council transmittal of a proposed fishery management plan, proposed plan amendment, or proposed regulations to the U.S. Secretary of Commerce, under sections 304 or 305 of the MSA. Opportunities to present oral public comment will be provided throughout the agendas. The order in which agenda items is addressed may change and will be announced in advance at the meetings. The meetings may run past the scheduled times noted above to complete scheduled business. Background documents for the 175th Council meeting will be available at https://www.wpcouncil.org. Written VerDate Sep<11>2014 16:52 Nov 30, 2018 Jkt 247001 public comments for the 175th Council meeting should be received at the Council office by 5 p.m. (HST), December 13, 2018, and should be sent to Kitty M. Simonds, Executive Director, Western Pacific Fishery Management Council, 1164 Bishop Street, Suite 1400, Honolulu, HI 96813; fax: (808) 522– 8226; or email: info.wpcouncil@ noaa.gov. Agenda for the PSAC Meeting Agenda for 175th Council Meeting Monday, December 17, 2018, 12 p.m.–2 p.m. (HST); Monday, December 17, 2018, 11 a.m.–1 p.m. (ASST); Tuesday, December 18, 2018, 8 a.m.–10 a.m. (MST) 1. Welcome and Introductions 2. Approval of the 175th Agenda 3. Managing Loggerhead and Leatherback Sea Turtle Interactions in the Hawaii-based Shallow-set Longline Fishery (Final Action Item) 4. Protected Species Advisory Committee Report and Recommendations 5. Public Comment 6. Council Discussion and Recommendations 7. Other Business Non-emergency issues not contained in this agenda may come before the Council for discussion and formal Council action during the 175th meeting. However, Council action on regulatory issues will be restricted to those issues specifically listed in this document and any regulatory issue arising after publication of this document that requires emergency action under section 305(c) of the Magnuson-Stevens Act, provided the public has been notified of the Council’s intent to take action to address the emergency. Special Accommodations These meetings are accessible to people with disabilities. Requests for Frm 00021 Fmt 4703 Sfmt 4703 Authority: 16 U.S.C. 1801 et seq. Dated: November 28, 2018. Tracey L. Thompson, Acting Deputy Director, Office of Sustainable Fisheries, National Marine Fisheries Service. [FR Doc. 2018–26185 Filed 11–30–18; 8:45 am] Monday, December 17, 2018, 9 a.m. to 11 a.m. (HST) 1. Welcome and Introductions 2. Approval of Agenda 3. Status of the Fifth Protected Species Advisory Committee Meeting Recommendations 4. Managing Loggerhead and Leatherback Sea Turtle Interactions in the Hawaii-based Shallow-set Longline Fishery 5. 2020–24 Research Priorities 6. Public Comment 7. Committee Discussion and Recommendations 8. Other Business and Next Meeting PO 00000 sign language interpretation or other auxiliary aids should be directed to Kitty M. Simonds, (808) 522–8220 (voice) or (808) 522–8226 (fax), at least 5 days prior to the meeting date. BILLING CODE 3510–22–P DEPARTMENT OF DEFENSE Office of the Secretary Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting Under Secretary of Defense for Personnel and Readiness, Uniform Formulary Beneficiary Advisory Panel, Department of Defense. ACTION: Notice of federal advisory committee meeting. AGENCY: The Department of Defense (DoD) is publishing this notice to announce that the following Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel will take place. DATES: Open to the public Thursday January 10, 2019 from 9:00 a.m. to 12:00 p.m. ADDRESSES: The address of the open meeting is the Naval Heritage Center Theater, 701 Pennsylvania Avenue NW, Washington, DC 20004. FOR FURTHER INFORMATION CONTACT: Colonel Paul J. Hoerner, USAF, 703– 681–2890 (Voice); None (Facsimile); dha.ncr.j-6.mbx.baprequests@mail.mil (Email). Mailing address is 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 22042–5101. Website: https://health.mil/bap. The most up-todate changes to the meeting agenda can be found on the website. SUPPLEMENTARY INFORMATION: This meeting is being held under the provisions of the Federal Advisory Committee Act (FACA) of 1972 (5 U.S.C., Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102–3.140 and 102–3.150. The Panel will review and comment on recommendations made to the Director of the Defense Health Agency, by the Pharmacy and Therapeutics Committee, regarding the Uniform Formulary. Purpose of the Meeting: The Department of Defense is publishing SUMMARY: E:\FR\FM\03DEN1.SGM 03DEN1 Federal Register / Vol. 83, No. 232 / Monday, December 3, 2018 / Notices this notice to announce a Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel (hereafter referred to as the Panel) will take place. Agenda: 1. Sign-In 2. Welcome and Opening Remarks 3. Scheduled Therapeutic Class Reviews (Comments will follow each agenda item) a. Neurological Agents Miscellaneous—Movement Disorders b. Gastrointestinal-2 Agents— Miscellaneous c. Gastrointestinal-2 Agents—CIC and IBS–C 4. Newly Approved Drugs Review 5. Pertinent Utilization Management Issues 6. Panel Discussions and Vote Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 41 Code of Federal Regulations (CFR) 102–3.140 through 102–3.165, and the availability of space, this meeting is open to the public. Seating is limited and will be provided only to the first 220 people signing-in. All persons must sign-in legibly. Written Statements: Pursuant to 41 CFR 102–3.140, the public or interested organizations may submit written statements to the membership of the Panel about its mission and/or the agenda to be addressed in this public meeting. Written statements should be submitted to the Panel’s Designated Federal Officer (DFO). The DFO’s contact information can be obtained previously in this announcement. Written comments or statements must be received by the committee DFO at least five (5) business days prior to the meeting so that they may be made available to the Panel for its consideration prior to the meeting. The DFO will review all submitted written statements and provide copies to all the committee members. Dated: November 28, 2018. Shelly E. Finke, Alternate OSD Federal Register Liaison Officer, Department of Defense. Anyone wishing to object to the grant of this license must file written objections along with supporting evidence, if any, not later than December 18, 2018. DATES: Written objections are to be filed with the Office of Research and Technology Applications, Naval Postgraduate School, Research and Sponsored Programs Office, NPS Code 41, 699 Dyer Road, Bldg. HA, Room 226, Monterey, CA 93943. ADDRESSES: Ms. Deborah Buettner, Director, Research and Sponsored Programs Office, NPS Code 41, 699 Dyer Road, Bldg. HA, Room 226, Monterey, CA 93943, telephone 831–656–7893. Due to U.S. Postal delays, please fax 831–656–2038, email: dbuettne@nps.edu or use courier delivery to expedite response. FOR FURTHER INFORMATION CONTACT: Authority: 35 U.S.C. 209(e); 37 CFR 404.7 [FR Doc. 2018–26188 Filed 11–30–18; 8:45 am] Dated: November 28, 2018. Meredith Steingold Werner, Commander, Judge Advocate General’s Corps, U.S. Navy, Federal Register Liaison Officer. BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE khammond on DSK30JT082PROD with NOTICES The Department of the Navy hereby gives notice of its intent to grant to Vedevo, Inc. (Capitola, CA) a revocable, nonassignable, exclusive license to practice in the field of use of data compression method for use in still images, in the field of use of data compression method for use in video streaming, in the field of use of data compression method for use in digital signal processing, in the field of use of data compression method for use in computer graphics, in the field of use of data compression method for use in video games, in the field of use of data compression method for use in virtual reality, in the field of use of data compression method for use in medical imaging & diagnostics, in the field of use of data compression method for use in data storage, in the field of use of data compression method for use in security systems, and in the field of use of data compression method for use in numerical methods, the GovernmentOwned invention described in U.S. Patent No. 8,526,746 issued September 3, 2013 titled ‘‘NEAR-LOSSLESS DATA COMPRESSION METHOD USING NONUNIFORM SAMPLING.’’ SUMMARY: [FR Doc. 2018–26212 Filed 11–30–18; 8:45 am] Department of the Navy BILLING CODE 3810–FF–P Notice of Intent To Grant Exclusive Patent License; Vedevo, Inc Department of the Navy, DoD. Notice of intent to grant license. AGENCY: ACTION: VerDate Sep<11>2014 16:52 Nov 30, 2018 Jkt 247001 PO 00000 Frm 00022 Fmt 4703 Sfmt 4703 62311 DEPARTMENT OF EDUCATION [Docket No.: ED–2018–ICCD–0125] Agency Information Collection Activities; Comment Request; Study of State Implementation of the Unsafe School Choice Option Office of Planning, Evaluation, and Policy Development (OPEPD), Department of Education (ED). ACTION: Notice. AGENCY: In accordance with the Paperwork Reduction Act of 1995, ED is proposing a new information collection. DATES: Interested persons are invited to submit comments on or before February 1, 2019. ADDRESSES: To access and review all the documents related to the information collection listed in this notice, please use https://www.regulations.gov by searching the Docket ID number ED– 2018–ICCD–0125. Comments submitted in response to this notice should be submitted electronically through the Federal eRulemaking Portal at https:// www.regulations.gov by selecting the Docket ID number or via postal mail, commercial delivery, or hand delivery. Please note that comments submitted by fax or email and those submitted after the comment period will not be accepted. Written requests for information or comments submitted by postal mail or delivery should be addressed to the Director of the Information Collection Clearance Division, U.S. Department of Education, 550 12th Street SW, PCP, Room 9089, Washington, DC 20202–0023. FOR FURTHER INFORMATION CONTACT: For specific questions related to collection activities, please contact Erica Lee, 202– 260–1463. SUPPLEMENTARY INFORMATION: The Department of Education (ED), in accordance with the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3506(c)(2)(A)), provides the general public and Federal agencies with an opportunity to comment on proposed, revised, and continuing collections of information. This helps the Department assess the impact of its information collection requirements and minimize the public’s reporting burden. It also helps the public understand the Department’s information collection requirements and provide the requested data in the desired format. ED is soliciting comments on the proposed information collection request (ICR) that is described below. The Department of Education is especially interested in public comment addressing the following issues: (1) Is this collection SUMMARY: E:\FR\FM\03DEN1.SGM 03DEN1

Agencies

[Federal Register Volume 83, Number 232 (Monday, December 3, 2018)]
[Notices]
[Pages 62310-62311]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-26188]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Uniform Formulary Beneficiary Advisory Panel; Notice of Federal 
Advisory Committee Meeting

AGENCY: Under Secretary of Defense for Personnel and Readiness, Uniform 
Formulary Beneficiary Advisory Panel, Department of Defense.

ACTION: Notice of federal advisory committee meeting.

-----------------------------------------------------------------------

SUMMARY: The Department of Defense (DoD) is publishing this notice to 
announce that the following Federal Advisory Committee meeting of the 
Uniform Formulary Beneficiary Advisory Panel will take place.

DATES: Open to the public Thursday January 10, 2019 from 9:00 a.m. to 
12:00 p.m.

ADDRESSES: The address of the open meeting is the Naval Heritage Center 
Theater, 701 Pennsylvania Avenue NW, Washington, DC 20004.

FOR FURTHER INFORMATION CONTACT: Colonel Paul J. Hoerner, USAF, 703-
681-2890 (Voice); None (Facsimile); [email protected] (Email). Mailing address is 7700 Arlington 
Boulevard, Suite 5101, Falls Church, VA 22042-5101. Website: https://health.mil/bap. The most up-to-date changes to the meeting agenda can 
be found on the website.

SUPPLEMENTARY INFORMATION: This meeting is being held under the 
provisions of the Federal Advisory Committee Act (FACA) of 1972 (5 
U.S.C., Appendix, as amended), the Government in the Sunshine Act of 
1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.140 and 102-3.150.
    The Panel will review and comment on recommendations made to the 
Director of the Defense Health Agency, by the Pharmacy and Therapeutics 
Committee, regarding the Uniform Formulary.
    Purpose of the Meeting: The Department of Defense is publishing

[[Page 62311]]

this notice to announce a Federal Advisory Committee meeting of the 
Uniform Formulary Beneficiary Advisory Panel (hereafter referred to as 
the Panel) will take place.
    Agenda:
1. Sign-In
2. Welcome and Opening Remarks
3. Scheduled Therapeutic Class Reviews (Comments will follow each 
agenda item)
    a. Neurological Agents Miscellaneous--Movement Disorders
    b. Gastrointestinal-2 Agents--Miscellaneous
    c. Gastrointestinal-2 Agents--CIC and IBS-C
4. Newly Approved Drugs Review
5. Pertinent Utilization Management Issues
6. Panel Discussions and Vote

    Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 
41 Code of Federal Regulations (CFR) 102-3.140 through 102-3.165, and 
the availability of space, this meeting is open to the public. Seating 
is limited and will be provided only to the first 220 people signing-
in. All persons must sign-in legibly.
    Written Statements: Pursuant to 41 CFR 102-3.140, the public or 
interested organizations may submit written statements to the 
membership of the Panel about its mission and/or the agenda to be 
addressed in this public meeting. Written statements should be 
submitted to the Panel's Designated Federal Officer (DFO). The DFO's 
contact information can be obtained previously in this announcement. 
Written comments or statements must be received by the committee DFO at 
least five (5) business days prior to the meeting so that they may be 
made available to the Panel for its consideration prior to the meeting. 
The DFO will review all submitted written statements and provide copies 
to all the committee members.

    Dated: November 28, 2018.
Shelly E. Finke,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2018-26188 Filed 11-30-18; 8:45 am]
 BILLING CODE 5001-06-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.